199 related articles for article (PubMed ID: 12843744)
1. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection.
Ariyoshi K; Matsuda M; Miura H; Tateishi S; Yamada K; Sugiura W
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):336-42. PubMed ID: 12843744
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
3. Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.
Avidor B; Turner D; Mor Z; Chalom S; Riesenberg K; Shahar E; Pollack S; Elbirt D; Sthoeger Z; Maayan S; Olshtain-Pops K; Averbuch D; Chowers M; Istomin V; Anis E; Mendelson E; Ram D; Levy I; Grossman Z
PLoS One; 2013; 8(3):e57789. PubMed ID: 23469241
[TBL] [Abstract][Full Text] [Related]
4. Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.
Praparattanapan J; Kotarathitithum W; Chaiwarith R; Nuntachit N; Sirisanthana T; Supparatpinyo K
Curr HIV Res; 2012 Dec; 10(8):647-52. PubMed ID: 23061604
[TBL] [Abstract][Full Text] [Related]
5. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
Li S; Ouyang J; Zhao B; An M; Wang L; Ding H; Zhang M; Han X
BMC Infect Dis; 2020 Feb; 20(1):123. PubMed ID: 32046664
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
Vergne L; Peeters M; Mpoudi-Ngole E; Bourgeois A; Liegeois F; Toure-Kane C; Mboup S; Mulanga-Kabeya C; Saman E; Jourdan J; Reynes J; Delaporte E
J Clin Microbiol; 2000 Nov; 38(11):3919-25. PubMed ID: 11060045
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
Jørgensen LB; Christensen MB; Gerstoft J; Mathiesen LR; Obel N; Pedersen C; Nielsen H; Nielsen C
Scand J Infect Dis; 2003; 35(11-12):800-7. PubMed ID: 14723353
[TBL] [Abstract][Full Text] [Related]
8. Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia.
Indriati DW; Kotaki T; Khairunisa SQ; Witaningrum AM; Matondang MQY; Ueda S; Nasronudin ; Purnama A; Kurniawan D; Kameoka M
Curr HIV Res; 2018; 16(2):158-166. PubMed ID: 29732988
[TBL] [Abstract][Full Text] [Related]
9. Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE.
Maljkovic I; Wilbe K; Sölver E; Alaeus A; Leitner T
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):989-97. PubMed ID: 14678606
[TBL] [Abstract][Full Text] [Related]
10. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
[TBL] [Abstract][Full Text] [Related]
11. Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.
Yu G; Li Y; Huang X; Zhou P; Yan J; Yan X; Fu X; Fang Y; Liu J; Li J; He X; Lin P
Curr HIV Res; 2020; 18(3):210-218. PubMed ID: 32294040
[TBL] [Abstract][Full Text] [Related]
12. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.
Bakhouch K; Oulad-Lahcen A; Bensghir R; Blaghen M; Elfilali KM; Ezzikouri S; Abidi O; Hassar M; Wakrim L
J Infect Dev Ctries; 2009 Jun; 3(5):380-91. PubMed ID: 19759509
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data.
Fleury HJ; Toni T; Lan NT; Hung PV; Deshpande A; Recordon-Pinson P; Boucher S; Lazaro E; Jauvin V; Lavignolle-Aurillac V; Lebel-Binay S; Cheret A; Masquelier B
AIDS Res Hum Retroviruses; 2006 Apr; 22(4):357-66. PubMed ID: 16623640
[TBL] [Abstract][Full Text] [Related]
15. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
[TBL] [Abstract][Full Text] [Related]
16. The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia.
Indriati DW; Witaningrum AM; Yunifiar MQ; Khairunisa SQ; Ueda S; Kotaki T; Nasronudin N; Kameoka M
Acta Med Indones; 2020 Oct; 52(4):366-374. PubMed ID: 33377882
[TBL] [Abstract][Full Text] [Related]
17. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
[TBL] [Abstract][Full Text] [Related]
18. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
[TBL] [Abstract][Full Text] [Related]
20. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
